Edgewise Therapeutics, Inc. (EWTX)
29.55
-0.25
(-0.84%)
USD |
NASDAQ |
Mar 24, 10:39
Edgewise Therapeutics EPS Diluted (Quarterly) : -0.4737 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -2.324 |
| Nuvalent, Inc. | -1.585 |
| Boston Scientific Corp. | 0.4493 |
| Edwards Lifesciences Corp. | 0.1104 |
| Eli Lilly & Co. | 7.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.22M |
| Total Expenses (Quarterly) | 50.22M |
| Enterprise Value | 2.671B |
| Earnings Yield | -5.52% |
| Normalized Earnings Yield | -5.524 |